Important Updates for Hims & Hers Investors
NEW YORK and NEW ORLEANS — In a significant development concerning Hims & Hers Health, Inc. (NASDAQ: HIMS), former Attorney General of Louisiana, Charles C. Foti, Jr., partnered with Kahn Swick & Foti, LLC, emphasizes the urgency for investors who have suffered losses exceeding $100,000 to take action. Investors are reminded that they have until August 25, 2025 to submit their lead plaintiff applications as part of ongoing securities class action lawsuits relating to Hims & Hers Health.
Understanding the Class Actions Against Hims & Hers
Hims & Hers, a company known for its telehealth services, is currently facing accusations tied to securities violations during its latest Class Period, which spans from April 29, 2025 to June 23, 2025. These lawsuits are being filed in the United States District Court for the Northern District of California. The allegations suggest that the company and certain executives failed to disclose crucial information that affected stock value and misled investors.
Key Events Impacting Hims & Hers Health
A pivotal moment occurred on June 23, 2025, when Novo Nordisk announced the termination of its partnership with Hims. This shocking news indicated that Hims had allegedly “failed to adhere to the law prohibiting mass sales of compounded drugs” and had engaged in practices that jeopardized patient safety. Consequently, the price of Hims shares plummeted by 34.6%, closing at $41.98 per share amid significant volume of trading.
What Should Hims Investors Do Next?
If you have purchased shares of Hims and are concerned about your legal rights regarding this situation, consider reaching out to Kahn Swick & Foti, LLC. There’s no cost or obligation to inquire about how this case may impact your potential recovery for financial losses. Moreover, if you are interested in stepping forward as a lead plaintiff, it’s essential to file your petition with the Court before the deadline.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC, armed with a reputable background in securities litigation, ranks among the top firms in the nation for recovery in investment cases. Their team is dedicated to representing both institutional and retail investors, striving for justice in the face of corporate fraud. The law firm operates out of various locations, including New York, California, and Luxembourg, ensuring a broad reach and committed support for their clients throughout the legal process.
Contact Information
For further assistance or to discuss your situation more directly, interested parties can contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
Email: lewis.kahn@ksfcounsel.com
Phone: 1-877-515-1850
Address: 1100 Poydras St., Suite 960
New Orleans, LA 70163
Frequently Asked Questions
What is the focus of the lawsuits against Hims & Hers Health?
The lawsuits focus on allegations that the company and its executives failed to disclose essential information to investors that affected the stock's value.
When is the deadline to file as a lead plaintiff?
The deadline to file applications for lead plaintiff status is August 25, 2025.
What caused the drop in Hims stock price?
The stock price plunging was primarily triggered by the announcement of the terminated partnership with Novo Nordisk, which raised serious concerns about compliance and safety.
How can I contact Kahn Swick & Foti for legal assistance?
You can reach them via email at lewis.kahn@ksfcounsel.com or call 1-877-515-1850.
What services does Kahn Swick & Foti provide?
They provide legal representation to investors facing losses due to corporate misconduct and help in class action lawsuits.
